Abstract
Rapid Translation System (RTS) is a cell-free protein production system employing an enhanced Escherichia coli lysate to perform coupled in vitro transcription-translation reactions. A continuous supply of energy substrates, nucleotides and amino acids combined with the removal of by-products guarantees a high yield of protein production. The gene to express is either cloned into a plasmid vector or introduced as a PCR product amenable to automation. The main property of this alternative system to cellular expression systems is its open design allowing direct manipulation of the reaction conditions and applications that are impossible or difficult in cell-based systems. RTS offers new promising possibilities in the postgenomic era.
Keywords: rapid translation system, rts, recombinant protein
Current Protein & Peptide Science
Title: Rapid Translation System (RTS): A Promising Alternative for Recombinant Protein Production
Volume: 4 Issue: 1
Author(s): J.- M. Betton
Affiliation:
Keywords: rapid translation system, rts, recombinant protein
Abstract: Rapid Translation System (RTS) is a cell-free protein production system employing an enhanced Escherichia coli lysate to perform coupled in vitro transcription-translation reactions. A continuous supply of energy substrates, nucleotides and amino acids combined with the removal of by-products guarantees a high yield of protein production. The gene to express is either cloned into a plasmid vector or introduced as a PCR product amenable to automation. The main property of this alternative system to cellular expression systems is its open design allowing direct manipulation of the reaction conditions and applications that are impossible or difficult in cell-based systems. RTS offers new promising possibilities in the postgenomic era.
Export Options
About this article
Cite this article as:
Betton M. J.-, Rapid Translation System (RTS): A Promising Alternative for Recombinant Protein Production, Current Protein & Peptide Science 2003; 4 (1) . https://dx.doi.org/10.2174/1389203033380359
DOI https://dx.doi.org/10.2174/1389203033380359 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Epigenetic Regulation in Tooth Development and Regeneration
Current Stem Cell Research & Therapy Bioorganic Approaches Towards HIV Vaccine Design
Current Pharmaceutical Design Ethyl Pyruvate: A Novel Treatment for Sepsis
Current Drug Targets Targeting EGFR in Pancreatic Cancer Treatment
Current Drug Targets Cancer Stem Cells: How can we Target them?
Current Medicinal Chemistry Vascular and Cardiac Oxidative Stress and Inflammation as Targets for Cardioprotection
Current Pharmaceutical Design Dynamics of Virus-Host Interplay in HIV-1 Replication
Current HIV Research Severe Hyponatremia and Other Electrolyte Disturbances Associated with Indapamide
Current Drug Safety Epigenetics in Alzheimers Disease: a Focus on DNA Modifications
Current Pharmaceutical Design Hepatic Gene Transfer as a Means of Tolerance Induction to Transgene Products
Current Gene Therapy Poor Nutrition with Aging: an “Oxidatively Stressing” Condition
Current Nutrition & Food Science Determinants of Longevity: Genetics, Biomarkers and Therapeutic Approaches
Current Pharmaceutical Design The Urokinase Receptor Interactome
Current Pharmaceutical Design Therapeutic Strategies to Target TGF-β in the Treatment of Bone Metastases
Current Pharmaceutical Biotechnology Blood-Brain Barrier Transport of Cytokines: A Mechanism for Neuropathology
Current Pharmaceutical Design Genetic Markers of Osteoarthritis
Current Rheumatology Reviews Restoring the Dysfunctional Endothelium
Current Pharmaceutical Design Mitochondria-Targeted Drugs
Current Molecular Pharmacology Antioxidant Therapy in Alzheimers Disease: Theory and Practice
Mini-Reviews in Medicinal Chemistry Amyloid Forming Proteases: Therapeutic Targets for Alzheimers Disease
Current Pharmaceutical Design